BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent
27 août 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
15 août 2024 16h15 HE
|
Alvotech
Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023 Product revenues for the first six months were $66...
European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
15 août 2024 04h30 HE
|
Alvotech
The approvals process is anticipated to be completed in the third quarter of 2025 REYKJAVIK, Iceland and LONDON, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company...
Alvotech mun birta uppgjör fyrri árshelmings 2024 fimmtudaginn 15. ágúst nk. og streyma uppgjörsfundi föstudaginn 16. ágúst nk. kl. 12:00 að íslenskum tíma
01 août 2024 16h01 HE
|
Alvotech
Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrir fyrri helming ársins 2024 eftir lokun markaða í Bandaríkjunum, fimmtudaginn 15. ágúst nk. Þá mun Alvotech halda kynningarfund fyrir...
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
01 août 2024 16h01 HE
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first half of the...
Plant Advanced Techonolgies : Hausse du Chiffre d’Affaires Combiné au 30 juin 2024
22 juil. 2024 12h36 HE
|
Plant Advanced Technologies
Vandœuvre-lès-Nancy, le 22 juillet 2024 - 18 : 30 (CET) Communiqué de pressePour diffusion immédiate Hausse du Chiffre d’Affaires Combiné au 30 juin 2024 Chiffre d’affaires semestriel non audité du...
Amendment of Disclosures in Past Management Information Circulars
16 juil. 2024 18h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities Commission, BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:...
Alvotech Announces Closing of Private Debt Financing
11 juil. 2024 04h45 HE
|
Alvotech
REYKJAVIK, Iceland, July 11, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
BetterLife Announces Closing of a Private Placement
02 juil. 2024 18h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Alvotech Issues New Shares to Holders of Convertible Bonds
01 juil. 2024 17h35 HE
|
Alvotech
REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...